This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Interleukin-1 Receptor Antagonist Protein (IL1RN), N-Met
Product Overview
BioVenic's Recombinant Equine Interleukin-1 Receptor Antagonist Protein (IL1RN), N-Met is a recombinant protein expressed from E.coli. Its predicted molecular weight is 17.5 kDa. The purity is>95% (SDS-PAGE).
Specifications
Target Information
Equine Interleukin-1 Receptor Antagonist Protein (IL-1Ra) in horses is a crucial modulator of the inflammatory response. It inhibits the activity of interleukin-1 by binding to the IL1R1 receptor, preventing signal transduction and thus reducing inflammation. This protein is used in the treatment of conditions like equine osteoarthritis, where IL-1 plays a significant role in disease progression.
Shipping and Storage
This product is shipped with dry ice. It is recommended to aliquote as needed and store at -80°C upon receipt. Reconstituted protein solution can be stored at 4°C for 1 week, at < -80°C for 12 months.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute at 100 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.Aliquote the reconstituted solution to minimise freeze-thaw cycles.